A retrospective cohort study indicated that anti-TNF therapy could effectively reduce the incidence of PD (184).Currently, several clinical trials of anti-inflammatory and immunological therapy for PD are underway, though no effective outcomes are available yet (5). The gene discussed is TNF; the disease is Parkinson disease.